JCUP XII   - Tokyo | Sept 12-13, 2024 (Japanese)

• Kim Sharp (University of Pennsylvania) – "Potency isn’t everything: Glucokinase Activators drugs for Type 2 Diabetes"
• Georgia McGaughey (Trilligant, LLC) – "Is AI capable of real-world drug discovery? Lessons from my career"
• Katrina Lexa (Nico Therapeutics) – "Where art thou, easy button? Accelerating small-biotech discovery with computation"
• Kim Branson (GSK) - "Large Language models and AI at GSK"
• Eric Manas (Treeline Biosciences) - “Why Scientific Collaborations Matter: A Personal History”
  
• 池口 満徳（横浜市立大学）- "Molecular Dynamics Simulations for Protein Kinases”
• 北尾 彰朗（東京工業大学）- "Mechanisms of Conformational Change, Association, and Dissociation of Proteins investigated by Parallel Cascade Selection Molecular Dynamics”
• 大川 和史（旭化成ファーマ株式会社）- "Advancing Molecular Fingerprints: Integrating Chemical Reactivity for Enhanced Precision”
• 山岸 祐介（中外製薬株式会社) - "Validation of New Methodology to Create Orally Available Cyclic Peptides for Intracellular Tough Targets”

OpenEye 講演者

• Anthony Nicholls - "IIntroduction to JCUP and to OpenEye Cadence Molecular Sciences”
• Geoff Skillman - "OpenEye Science Review”
• Kalistyn Burley - "Innovative Molecular Design and Collaboration with Orion^®”
• David LeBard - "Expanding the druggable universe: Validation of a cryptic pocket detection workflow on several difficult-to-drug targets”
• Matt Geballe - "Faster, Larger, Smarter: Filling the funnel and advancing the scale of Virtual Screening”
• Chris Neale - "Optimizing Lead Compounds with Efficient Binding Free Energy Calculations” 
• Jesper Sorensen - "Development-ability of Antibody Therapeutics”

Download Program Agenda

(Updated September 2024)